Posttranscriptional regulation of splicing factor SRSF1 and its role in cancer cell biology

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Gonçalves, Vânia ^a,b   Jordan, Peter ^a,b  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CARBOPLATIN; ENDOGLIN; INITIATION FACTOR 4E; LAMIN A; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PACLITAXEL; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN BCL XL; PROTEIN MCL 1; PROTEIN NEK2; PROTEIN SERINE THREONINE KINASE; PROTEIN SRSF1; REGULATOR PROTEIN; RNA BINDING PROTEIN; SOMATOMEDIN C; SURVIVIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN A; SERINE ARGININE RICH SPLICING FACTOR; SRSF1 PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; APOPTOSIS; CANCER CELL; CARCINOGENESIS; CELL SURVIVAL; CYTOLOGY; CYTOPLASM; DNA FRAGMENTATION; ENZYME ACTIVITY; EXON; GENE EXPRESSION; HISTONE MODIFICATION; HUMAN; INTERNAL RIBOSOME ENTRY SITE; LUNG CANCER; MOLECULAR MECHANICS; NEGATIVE FEEDBACK; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; TRANSCRIPTION REGULATION; CELL NUCLEUS; GENETICS; NEOPLASM; PHYSIOLOGY; RNA INTERFERENCE;

ALTERNATIVE SPLICING; CELL NUCLEUS; CYTOPLASM; HUMANS; NEOPLASMS; RNA INTERFERENCE; SERINE-ARGININE SPLICING FACTORS;

EID: 84939152676     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/287048     Document Type: Review

References (109)

1. M. Chen and J. L. Manley, "Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches," Nature Reviews Molecular Cell Biology, vol. 10, no. 11, pp. 741-754, 2009.
2. A. Castello, B. Fischer, K. Eichelbaum et al. , "Insights into RNA biology from an atlas of mammalian mRNA-binding proteins," Cell, vol. 149, no. 6, pp. 1393-1406, 2012.
3. D. Ray, H. Kazan, K. B. Cook et al. , "A compendium of RNAbinding motifs for decoding gene regulation," Nature, vol. 499, no. 7457, pp. 172-177, 2013.
4. K. J. Hertel, "Combinatorial control of exon recognition," The Journal of Biological Chemistry, vol. 283, no. 3, pp. 1211-1215, 2008.
5. C. W. J. Smith and J. Valćarcel, "Alternative pre-mRNA splicing: the logic of combinatorial control," Trends in Biochemical Sciences, vol. 25, no. 8, pp. 381-388, 2000.
6. J. L. Manley and A. R. Krainer, "A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins)," Genes and Development, vol. 24, no. 11, pp. 1073-1074, 2010.
7. P. J. Smith, C. Zhang, J. Wang, S. L. Chew, M. Q. Zhang, and A. R. Krainer, "An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers," HumanMolecular Genetics, vol. 15, no. 16, pp. 2490-2508, 2006.
8. J. R. Sanford, X. Wang, M. Mort et al. , "Splicing factor SFRS1 recognizes a functionally diverse land scape of RNAtranscripts," Genome Research, vol. 19, no. 3, pp. 381-394, 2009.
9. L. F. Lareau, M. Inada, R. E. Green, J. C. Wengrod, and S. E. Brenner, "Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements," Nature, vol. 446, no. 7138, pp. 926-929, 2007.
10. C. Valacca, S. Bonomi, E. Buratti et al. , "Sam68 regulates EMTthrough alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene," The Journal of Cell Biology, vol. 191, no. 1, pp. 87-99, 2010.
11. S. Sun, Z. Zhang, R. Sinha, R. Karni, and A. R. Krainer, "SF2/ASF autoregulation involves multiple layers of posttranscriptional and translational control," Nature Structural and Molecular Biology, vol. 17, no. 3, pp. 306-312, 2010.
12. J. R. Sanford, P. Coutinho, J. A. Hackett, X. Wang, W. Ranahan, and J. F. Caceres, "Identification of nuclear and cytoplasmic mRNA targets for the shuttling protein SF2/ASF," PLoS ONE, vol. 3, no. 10, Article ID e3369, 2008.
13. L. Verduci, M. Simili, M. Rizzo et al. , "MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis," Journal of Biological Chemistry, vol. 285, no. 50, pp. 39551-39563, 2010.
14. S. Meseguer, G. Mudduluru, J. M. Escamilla, H. Allgayer, and D. Barettino, "MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF)," The Journal of Biological Chemistry, vol. 286, no. 6, pp. 4150-4164, 2011.
15. J. C. Hagopian, C.-T. Ma, B. R. Meade et al. , "Adaptable molecular interactions guide phosphorylation of the SR protein ASF/SF2 by SRPK1," Journal of Molecular Biology, vol. 382, no. 4, pp. 894-909, 2008.
16. M.-C. Lai, R.-I. Lin, and W.-Y. Tarn, "Transportin-SR2mediates nuclear import of phosphorylated SR proteins," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10154-10159, 2001.
17. J. F. Ćaceres, T. Misteli, G. R. Screaton, D. L. Spector, and A. R. Krainer, "Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity," Journal of Cell Biology, vol. 138, no. 2, pp. 225-238, 1997.
18. N. Kataoka, J. L. Bachorik, and G. Dreyfuss, "Transportin-SR, a nuclear import receptor for SR proteins," Journal of Cell Biology, vol. 145, no. 6, pp. 1145-1152, 1999.
19. K. Colwill, T. Pawson, B. Andrews et al. , "The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution,"EMBOJournal, vol. 15, no. 2, pp. 265-275, 1996.
20. J. C. K. Ngo, S. Chakrabarti, J.-H. Ding et al. , "Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2," Molecular Cell, vol. 20, no. 1, pp. 77-89, 2005.
21. G. Ghosh and J. A. Adams, "Phosphorylation mechanism and structure of serine-arginine protein kinases,"The FEBS Journal, vol. 278, no. 4, pp. 587-597, 2011.
22. T. Misteli, J. F. Ćaceres, and D. L. Spector, "The dynamics of a pre-mRNA splicing factor in living cells," Nature, vol. 387, no. 6632, pp. 523-527, 1997.
23. J.-F. Gui, W. S. Lane, and X.-D. Fu, "A serine kinase regulates intracellular localization of splicing factors in the cell cycle," Nature, vol. 369, no. 6482, pp. 678-682, 1994.
24. J.-H. Ding, "Regulated cellular partitioning of SR proteinspecific kinases in mammalian cells," Molecular Biology of the Cell, vol. 17, pp. 876-885, 2005.
25. T. Giannakouros, E. Nikolakaki, I. Mylonis, and E. Georgatsou, "Serine-arginine protein kinases: a small protein kinase family with a large cellular presence," FEBS Journal, vol. 278, no. 4, pp. 570-586, 2011.
26. Z. Zhou, J. Qiu, W. Liuet al. , "TheAkt-SRPK-SRaxis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus," Molecular Cell, vol. 47, no. 3, pp. 422-433, 2012.
27. B. E. Aubol, R. M. Plocinik, J. C. Hagopian et al. , "Partitioning RS domain phosphorylation in an SR protein through the CLK and SRPK protein kinases," Journal of Molecular Biology, vol. 425, no. 16, pp. 2894-2909, 2013.
28. X.-Y. Zhong, J.-H. Ding, J. A. Adams, G. Ghosh, and X.-D. Fu, "Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones," Genes and Development, vol. 23, no. 4, pp. 482-495, 2009.
29. J. Shi, W. Qian, X. Yin et al. , "Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease," The Journal of Biological Chemistry, vol. 286, no. 16, pp. 14639-14648, 2011.
30. A. K. Aksaas, S. Eikvar, G. Akusjärvi, B. S. Skålhegg, and A. K. Kvissel, "Protein Kinase a-dependent phosphorylation of serine 119 in the proto-oncogenic serine/arginine-rich splicing factor 1 modulates its activity as a splicing enhancer protein," Genes and Cancer, vol. 2, no. 8, pp. 841-851, 2011.
31. F. Rossi, E. Labourier, T. Forńe et al. , "Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I," Nature, vol. 381, no. 6577, pp. 80-82, 1996.
32. E. Labourier, F. Rossi, I.-E. Gallouzi, E. Allemand , G. Divita, and J. Tazi, "Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor," Nucleic Acids Research, vol. 26, no. 12, pp. 2955-2962, 1998.
33. J. Soret, M. Gabut, C. Dupon et al. , "Altered serine/argininerich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I," Cancer Research, vol. 63, no. 23, pp. 8203-8211, 2003.
34. M. Malanga, A. Czubaty, A. Girstun, K. Staron, and F. R. Althaus, "Poly(ADP-ribose) binds to the splicing factor ASF/SF2 and regulates its phosphorylation by DNA topoisomerase I," Journal of Biological Chemistry, vol. 283, no. 29, pp. 19991-19998, 2008.
35. X. Li and J. L. Manley, "Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability," Cell, vol. 122, no. 3, pp. 365-378, 2005.
36. A. El Hage, S. L. French, A. L. Beyer, and D. Tollervey, "Loss of Topoisomerase I leads to R-loop-mediated transcriptional blocks during ribosomal RNA synthesis," Genes and Development, vol. 24, no. 14, pp. 1546-1558, 2010.
37. M. Blaustein, F. Pelisch, T. Tanos et al. , "Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT," Nature Structural and Molecular Biology, vol. 12, no. 12, pp. 1037-1044, 2005.
38. K. Jiang, N. A. Patel, J. E. Watson et al. , "Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCβJII messenger ribonucleic acid," Endocrinology, vol. 150, no. 5, pp. 2087-2097, 2009.
39. P. Wang, Z. Zhou, A. Hu et al. , "Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPPmediated dephosphorylation ofAkt,"Molecular Cell, vol. 54, no. 3, pp. 378-391, 2014.
40. C. Naro, F. Barbagallo, P. Chieffi, C. F. Bourgeois, M. P. Paronetto, and C. Sette, "The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival," Nucleic Acids Research, vol. 42, no. 5, pp. 3218-3227, 2014.
41. D. Cazalla, J. Zhu, L. Manche, E. Huber, A. R. Krainer, and J. F. Ćaceres, "Nuclear export and retention signals in the RS domain of SR proteins," Molecular and Cellular Biology, vol. 22, no. 19, pp. 6871-6882, 2002.
42. D. G. Nowak, E. M. Amin, E. S. Rennel et al. , "Regulation of Vascular Endothelial Growth Factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis," Journal of Biological Chemistry, vol. 285, no. 8, pp. 5532-5540, 2010.
43. V. Goncalves, A. Henriques, J. Pereira et al. , "Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells," RNA, vol. 20, no. 4, pp. 474-482, 2014.
44. T. Misteli and D. L. Spector, "Serine/threonine phosphatase 1 modulates the subnuclear distribution of pre-mRNA splicing factors," Molecular Biology of the Cell, vol. 7, no. 10, pp. 1559-1572, 1996.
45. T. Novoyatleva, B. Heinrich, Y. Tang et al. , "Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing," Human Molecular Genetics, vol. 17, no. 1, pp. 52-70, 2008.
46. C.-T. Ma, G. Ghosh, X.-D. Fu, and J. A. Adams, "Mechanism of dephosphorylation of the SR protein ASF/SF2 by protein phosphatase 1," Journal of Molecular Biology, vol. 403, no. 3, pp. 386-404, 2010.
47. G. Biamonti and J. F. Caceres, "Cellular stress and RNA splicing," Trends in Biochemical Sciences, vol. 34, no. 3, pp. 146-153, 2009.
48. F. J. Blanco and C. Bernabeu, "The splicing factor SRSF1 as a marker for endothelial senescence," Frontiers in Physiology, vol. 3, article 54, 2012.
49. V. Leva, S. Giuliano, A. Bardoni et al. , "Phosphorylation of SRSF1 is modulated by replicational stress," Nucleic Acids Research, vol. 40, no. 3, pp. 1106-1117, 2012.
50. R. Sinha, E. Allemand , Z. Zhang, R. Karni, M. P. Myers, and A. R. Krainer, "Arginine methylation controls the subcellular localization and functions of the oncoprotein splicing factor SF2/ASF," Molecular and Cellular Biology, vol. 30, no. 11, pp. 2762-2774, 2010.
51. V. Tripathi, D. Y. Song, X. Zong et al. , "SRSF1 regulates the assembly of pre-mRNA processing factors in nuclear speckles," Molecular Biology of the Cell, vol. 23, no. 18, pp. 3694-3706, 2012.
52. Y. Kurogi, Y. Matsuo, Y. Mihara et al. , "Identification of a chemical inhibitor for nuclear speckle formation: Implications for the function of nuclear speckles in regulation of alternative pre-mRNA splicing," Biochemical and Biophysical Research Communications, vol. 446, no. 1, pp. 119-124, 2014.
53. V. Gonçalves, P. Matos, and P. Jordan, "The β-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression," RNA, vol. 14, no. 12, pp. 2538-2549, 2008.
54. Ú. Muñoz, J. E. Puche, R. Hannivoort, U. E. Lang, M. Cohen-Naftaly, and S. L. Friedman, "Hepatocyte growth factor enhances alternative splicing of the Krüppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1," Molecular Cancer Research, vol. 10, no. 9, pp. 1216-1227, 2012.
55. V. R. Moulton, A. R. Gillooly, and G. C. Tsokos, "Ubiquitination regulates expression of the serine/argininerich splicing factor 1 (SRSF1) in normal and systemic lupus erythematosus (SLE)-Rftxt cells," Journal of Biological Chemistry, vol. 289, no. 7, pp. 4126-4134, 2014.
56. A. K. Yadav, V. Vashishta, N. Joshi, and P. Taneja, "AR-A 014418 used against GSK3beta downregulates expression of hnRNPA1 and SF2/ASF splicing factors," Journal of Oncology, vol. 2014, Article ID 695325, 9 pages, 2014.
57. O. Breig and F. Baklouti, "Proteasome-mediated proteolysis of SRSF5 splicing factor intriguingly co-occurs with SRSF5mRNA upregulation during late erythroid differentiation," PLoS ONE, vol. 8, no. 3, Article IDe59137, 2013.
58. H. Sato, N. Hosoda, and L. E. Maquat, "Efficiency of the pioneer round of translation affects the cellular site of nonsensemediated mRNA decay," Molecular Cell, vol. 29, no. 2, pp. 255-262, 2008.
59. M.-C. Lai and W.-Y. Tarn, "Hypophosphorylated ASF/SF2 binds TAP and is present in messenger ribonucleoproteins," The Journal of Biological Chemistry, vol. 279, no. 30, pp. 31745-31749, 2004.
60. J. R. Sanford, N. K. Gray, K. Beckmann, and J. F. Ćaceres, "A novel role for shuttling SR proteins inmRNAtranslation," Genes and Development, vol. 18, no. 7, pp. 755-768, 2004.
61. M. M. Maslon, S. R. Heras, N. Bellora, E. Eyras, and J. F. Ćaceres, "The translational land scape of the splicing factor SRSF1 and its role in mitosis," eLife, vol. 2014, no. 3, Article IDe02028, 2014.
62. M. Blaustein, L. Quadrana, G. Risso, M. De LaMata, F. Pelisch, and A. Srebrow, "SF2/ASF regulates proteomic diversity by affecting the balance between translation initiation mechanisms," Journal of Cellular Biochemistry, vol. 107, no. 4, pp. 826-833, 2009.
63. G. Michlewski, J. R. Sanford, and J. F. Ćaceres, "The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1," Molecular Cell, vol. 30, no. 2, pp. 179-189, 2008.
64. Z. Zhang and A. R. Krainer, "Involvement of SR proteins in mRNA surveillance," Molecular Cell, vol. 16, no. 4, pp. 597-607, 2004.
65. H. Wu, S. Sun, K. Tu et al. , "A splicing-independent function of SF2/ASF in microRNA processing," Molecular Cell, vol. 38, no. 1, pp. 67-77, 2010.
66. F. Pelisch, J. Gerez, J. Druker et al. , "The serine/arginine-rich protein SF2/ASF regulates protein sumoylation," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 37, pp. 16119-16124, 2010.
67. R. J. Loomis, Y. Naoe, J. B. Parker et al. , "Chromatin binding of SRp20 and ASF/SF2 and dissociation from mitotic chromosomes is modulated by histone H3 serine 10 phosphorylation," Molecular Cell, vol. 33, no. 4, pp. 450-461, 2009.
68. M. M. Pradeepa, H. G. Sutherland , J. Ule, G. R. Grimes, and W. A. Bickmore, "Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing," PLoS Genetics, vol. 8, no. 5, Article ID e1002717, 2012.
69. V. Visconte, H. Makishima, J. P. MacIejewski, and R. V. Tiu, "Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders," Leukemia, vol. 26, no. 12, pp. 2447-2454, 2012.
70. C. Ghigna, M. Moroni, C. Porta, S. Riva, and G. Biamonti, "Altered expression of heterogeneous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas," Cancer Research, vol. 58, no. 24, pp. 5818-5824, 1998.
71. E. Stickeler, F. Kittrell, D. Medina, and S. M. Berget, "Stagespecific changes in SR splicing factors and alternative splicing in mammary tumorigenesis," Oncogene, vol. 18, no. 24, pp. 3574-3582, 1999.
72. J. P. Venables, "Aberrant and alternative splicing in cancer," Cancer Research, vol. 64, no. 21, pp. 7647-7654, 2004.
73. R. Karni, E. De Stanchina, S. W. Lowe, R. Sinha, D. Mu, and A. R. Krainer, "The gene encoding the splicing factor SF2/ASF is a proto-oncogene," Nature Structural and Molecular Biology, vol. 14, no. 3, pp. 185-193, 2007.
74. S. Gout, E. Brambilla, A. Boudria et al. , "Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma," PLoS ONE, vol. 7, no. 10, Article ID e46539, 2012.
75. L. Zou, H. Zhang, C. Du et al. , "Correlation of SRSF1 and PRMT1 expression with clinical status of pediatric acute lymphoblastic leukemia," Journal of Hematology and Oncology, vol. 5, article 42, 2012.
76. W. P. Tansey, "Mammalian MYC proteins and cancer," New Journal of Science, vol. 2014, Article ID 757534, 27 pages, 2014.
77. S. Das, O. Anczukow, M. Akerman, and A. R. Krainer, "Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC," Cell Reports, vol. 1, no. 2, pp. 110-117, 2012.
78. O. I. Fregoso, S. Das, M. Akerman, and A. R. Krainer, "Splicingfactor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence," Molecular Cell, vol. 50, no. 1, pp. 56-66, 2013.
79. O. Anczukow, A. Z. Rosenberg, M. Akermanet al. , "The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation," Nature Structural and Molecular Biology, vol. 19, no. 2, pp. 220-228, 2012.
80. P. E. Czabotar, G. Lessene, A. Strasser, and J. M. Adams, "Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy," Nature Reviews Molecular Cell Biology, vol. 15, no. 1, pp. 49-63, 2014.
81. A. Shimoni-Sebag, I. Lebenthal-Loinger, L. Zender, and R. Karni, "RRM1 domain of the splicing oncoprotein SRSF1 is required for MEK1-MAPK-ERK activation and cellular transformation," Carcinogenesis, vol. 34, no. 11, pp. 2498-2504, 2013.
82. H. L. Gautrey and A. J. Tyson-Capper, "Regulation of Mcl-1 by SRSF1 and SRSF5 in cancer cells," PLoS ONE, vol. 7, no. 12, Article ID e51497, 2012.
83. S. Leu, Y.-M. Lin, C.-H. Wu, and P. Ouyang, "Loss of Pnn expression results in mouse early embryonic lethality and cellular apoptosis through SRSF1-mediated alternative expression of Bcl-xS and ICAD," Journal of Cell Science, vol. 125, no. 13, pp. 3164-3172, 2012.
84. X. Li, J. Wang, and J. L. Manley, "Loss of splicing factor ASF/SF2 induces G2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation," Genes and Development, vol. 19, no. 22, pp. 2705-2714, 2005.
85. N. A. Olshavsky, C. E. S. Comstock, M. J. Schiewer et al. , "Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene," Cancer Research, vol. 70, no. 10, pp. 3975-3984, 2010.
86. F. Wang, H. Wang, H. Wu et al. , "TEAD1 controls C2C12 cell proliferation and differentiation and regulates three novel target genes," Cellular Signalling, vol. 25, no. 3, pp. 674-681, 2013.
87. R. Karni, Y. Hippo, S. W. Lowe, and A. R. Krainer, "The splicingfactor oncoprotein SF2/ASF activates mTORC1," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 40, pp. 15323-15327, 2008.
88. V. Ben-Hur, P. Denichenko, Z. Siegfried et al. , "S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1," Cell Reports, vol. 3, no. 1, pp. 103-115, 2013.
89. T. Ezponda, M. J. Pajares, J. Agorreta et al. , "The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression," Clinical Cancer Research, vol. 16, no. 16, pp. 4113-4125, 2010.
90. Y. Fu, B. Huang, Z. Shi et al. , "SRSF1 and SRSF9 RNA binding proteins promote Wnt signalling-mediated tumorigenesis by enhancing β-catenin biosynthesis," EMBO Molecular Medicine, vol. 5, no. 5, pp. 737-750, 2013.
91. C. Ghigna, S. Giordano, H. Shen et al. , "Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene,"MolecularCell, vol. 20, no. 6, pp. 881-890, 2005.
92. P. Jordan, R. Brazao, M. G. Boavida, C. Gespach, and E. Chastre, "Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors," Oncogene, vol. 18, no. 48, pp. 6835-6839, 1999.
93. A. Schnelzer, D. Prechtel, U. Knaus et al. , "Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b," Oncogene, vol. 19, no. 26, pp. 3013-3020, 2000.
94. P. Matos, J. G. Collard, and P. Jordan, "Tumor-related alternatively spliced Rac1b is not regulated by Rho-GDP dissociation inhibitors and exhibits selective downstream signaling," The Journal of Biological Chemistry, vol. 278, pp. 50442-50448, 2003.
95. D. Fiegen, L.-C. Haeusler, L. Blumenstein et al. , "Alternative splicing of rac1 generates Rac1b, a self-activating GTPase," Journal of Biological Chemistry, vol. 279, no. 6, pp. 4743-4749, 2004.
96. V. Gonçalves, P. Matos, and P. Jordan, "Antagonistic SRproteins regulate alternative splicing of tumor-related Rac1b downstreamof the PI3-kinase and Wnt pathways," HumanMolecular Genetics, vol. 18, no. 19, pp. 3696-3707, 2009.
97. P. Matos and P. Jordan, "Expression of Rac1b stimulates NF-κBmediated cell survival and G1/S progression," Experimental Cell Research, vol. 305, no. 2, pp. 292-299, 2005.
98. P. Matos and P. Jordan, "Increased Rac1b expression sustains colorectal tumor cell survival," Molecular Cancer Research, vol. 6, no. 7, pp. 1178-1184, 2008.
99. A. Maimon, M. Mogilevsky, A. Shilo et al. , "Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras-induced transformation," Cell Reports, vol. 7, no. 2, pp. 501-513, 2014.
100. F. J. deMiguel, R. D. Sharma, M. J. Pajares, L. M. Montuenga, A. Rubio, and R. Pio, "Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer," Cancer Research, vol. 74, no. 4, pp. 1105-1115, 2014.
101. D. G. Nowak, J. Woolard, E. M. Amin et al. , "Expression of pro-and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors," Journal of Cell Science, vol. 121, no. 20, pp. 3487-3495, 2008.
102. E. S. Rennel, A. H. R. Varey, A. J. Churchill et al. , "VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo," British Journal of Cancer, vol. 101, no. 7, pp. 1183-1193, 2009.
103. S. Oltean, M. Gammons, R. Hulse et al. , "SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases," Biochemical Society Transactions, vol. 40, no. 4, pp. 831-835, 2012.
104. M. N. Thobe, D. Gurusamy, P. Pathrose, and S. E. Waltz, "The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells," Oncogene, vol. 29, no. 2, pp. 214-226, 2010.
105. A. F. Muro, M. Caputi, R. Pariyarath, F. Pagani, E. Buratti, and F. E. Baralle, "Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display,"Molecular and Cellular Biology, vol. 19, no. 4, pp. 2657-2671, 1999.
106. I. C. Lopez-Mejia, M. de Toledo, F. Della Seta et al. , "Tissuespecific and SRSF1-dependent splicing of fibronectin, a matrix protein that controls host cell invasion,"Molecular Biology of the Cell, vol. 24, no. 20, pp. 3164-3176, 2013.
107. L. Adesso, S. Calabretta, F. Barbagallo et al. , "Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway," Oncogene, vol. 32, no. 23, pp. 2848-2857, 2013.
108. J. C. Shultz, R. W. Goehe, C. S. Murudkar et al. , "SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of nonsmall cell lung cancer cells," Molecular Cancer Research, vol. 9, no. 7, pp. 889-900, 2011.
109. J. C. Shultz, R. W. Goehe, D. S. Wijesinghe et al. , "Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a," Cancer Research, vol. 70, no. 22, pp. 9185-9196, 2010.